Daily activity and heart outcomes in people with chronic heart failure
Official title: Assessment of Physical Activity and Cardiovascular Outcomes in Patients With Chronic Heart Failure
Run by LMU Klinikum · NCT07460531 · Data updated 2026-11-12
We test whether tracking daily activity with pedometers and questionnaires can help predict heart-related events and hospital visits in adults with chronic heart failure.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | LMU Klinikum Academic / other |
| Locations | 2 sites (Munich, Bavaria and 1 other locations) |
| Status | Recruiting |
| Started | February 1, 2025 |
| Main results expected | December 31, 2030 |
| Study ends | June 30, 2031 |
| Registry record updated | March 11, 2026 |
| Trial ID | NCT07460531 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with chronic heart failure (NYHA II–IV) who have had NT‑proBNP >600 pg/ml, own a pedometer or activity device, and are physically able to walk would be ideal candidates.
✕Probably not a fit
Patients who cannot ambulate, lack a pedometer or reliable phone access, or who were hospitalized for heart failure within the past three months are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
SOPHIE is a prospective, multicentre observational cohort enrolling 2,000 adults with chronic heart failure. At baseline participants complete validated physical activity questionnaires (GPAQ, IPAQ, KCCQ) and provide seven-day step counts from consumer pedometers or wearable devices. Follow-up occurs every six months by telephone to repeat activity assessments and to record cardiovascular events, hospitalisations, and patient-reported outcomes. Inclusion requires prior NT-proBNP >600 pg/ml, NYHA II–IV status across any ejection fraction category, age ≥18, and ownership of a pedometer, while exclusion includes conditions preventing activity or heart-failure hospitalization within the last three months.
Why it matters
Potential benefit: If successful, the approach could help clinicians identify higher-risk patients earlier and support activity-based monitoring to reduce hospitalisations.
How similar studies have gone: Previous observational studies have linked wearable activity measures and questionnaire scores to outcomes in heart failure, but large prospective cohorts using consumer pedometers remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Heart failure NT-proBNP \>600 pg/ml (at least once in the history) NYHA-Class II-IV HFrEF - heart failure with reduced ejection fraction; LVEF ≤40% or HFmrEF - heart failure with mildly reduced ejection fraction; LVEF 41% - 49% or HFpEF - heart failure with preserved ejection fraction; LVEF ≥50% * Age ≥18 years old * Willingness to participate in the study, confirmed by a signed informed consent form * Ownership of a pedometer (e.g. smartwatch, activity tracker, smartphone-app, analogical pedometer) Exclusion Criteria: * Disease or disability that prevents physical activity * Hospitalisation due to heart failure within the last three months
Where it's running
-
LMU University Hospital
Munich, Bavaria, Germany Recruiting -
Central Hospital of Bolzano
Bolzano, Italy Recruiting
Study contacts
- Study coordinator: Stefan Brunner, MD
- Email: Stefan.Brunner@med.uni-muenchen.de
- Phone: +49 89 4400 0
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.